CytomX Therapeutics, Inc. (CTMX)
5.69
-0.05
(-0.87%)
USD |
NASDAQ |
Jan 30, 16:00
5.695
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Price : 5.69 for Jan. 30, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 11.16 |
| NovaBay Pharmaceuticals, Inc. | 1.86 |
| Palatin Technologies, Inc. | 14.71 |
| Theriva Biologics, Inc. | 0.18 |
| Oragenics, Inc. | 0.8408 |
Price Related Metrics
| PE Ratio | 13.61 |
| PS Ratio | 5.775 |
| PEG Ratio | 0.0928 |
| Price to Book Value | 8.978 |
| Earnings Yield | 7.35% |
| Market Cap | 964.09M |
| PEGY Ratio | 0.0928 |
| Operating PE Ratio | 28.35 |
| Normalized PE Ratio | 13.62 |